News Type: Treatment

PrEP Guidelines Let Young Black Gay and Bi Men Fall Through The Cracks

Guidelines from the Centers for Disease Control and Prevention (CDC) and other sources that identify individuals likely to benefit from Truvada (tenofovir disoproxil fumarate/emtricitabine) as pre-exposure prophylaxis (PrEP) are not sensitive or specific enough to identify many young Black men who have sex with men (MSM) at high risk for HIV, Reuters Health reports. A high proportion of individuals in a long-term cohort whom guidelines would not have indicated were at high risk for the virus contracted HIV over the course of a recent study.

Continue Reading…

Skip to toolbar